董事介绍
注:董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Ronald D. Green | 男 | Director | 64 | 24.25万美元 | 未持股 | 2025-11-03 |
| Catherine E. Woteki | -- | Director | 77 | 24.25万美元 | 未持股 | 2025-11-03 |
| Aashima Gupta | -- | Director | 54 | 23.50万美元 | 未持股 | 2025-11-03 |
| Mikhael Nassif | -- | Director,President and Chief Executive Officer | 49 | 未披露 | 未持股 | 2025-11-03 |
| Andrea F. Wainer | -- | Director | 57 | 未披露 | 未持股 | 2025-11-03 |
| Raphael A. Rodriguez | -- | Director | 57 | 23.50万美元 | 未持股 | 2025-11-03 |
| Thierry L. Bernard | -- | Director | 60 | 22.65万美元 | 未持股 | 2025-11-03 |
| Avi Pelossof | -- | Director | 62 | 未披露 | 未持股 | 2025-11-03 |
| James C. Borel | 男 | Chairman | 69 | 29.25万美元 | 未持股 | 2025-11-03 |
| Jeffrey D. Capello | 男 | Director | 60 | 23.75万美元 | 未持股 | 2025-11-03 |
高管介绍
注:高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| David H. Naemura | 男 | Chief Operating Officer | 57 | 268.02万美元 | 未持股 | 2025-11-03 |
| Amy M. Rocklin | 女 | Corporate Secretary, Chief Legal and Compliance Officer | 54 | 176.78万美元 | 未持股 | 2025-11-03 |
| Mikhael Nassif | -- | Director,President and Chief Executive Officer | 49 | 未披露 | 未持股 | 2025-11-03 |
| John Patrick Moylan | -- | Vice President, Corporate Controller and Chief Accounting Officer | -- | 未披露 | 未持股 | 2025-11-03 |
| Bryan Riggsbee | 男 | Senior Vice President and Chief Financial Officer | 55 | 未披露 | 未持股 | 2025-11-03 |
董事简历
中英对照 |  中文 |  英文- Ronald D. Green
-
Ronald D. Green,他是农业和自然资源学院(the Institute of Agriculture and Natural Resources)的哈伦副总会计师,以及内布拉斯加州大学(University of Nebraska)系统的农业与天然资源的副总裁。他曾担任Pfizer Animal Health公司的动物基因组学企业的负责技术服务的高级全球董事(从2008年到2010年)。他也曾任教于德州理工大学(Texas Tech University)和科罗拉多州立大学(Colorado State),也曾担任美国农业部农业研究服务局(the USDA’s Agricultural Research Service)的动物生产研究的国家项目领导人,以及白宫跨部门的动物基因组学的工作集团和国家科学技术委员会(the National Science and Technology Council)的执行秘书。他是国际牛、猪和绵羊的基因组测序项目领导人。他是the American Society of Animal Science(ASAS)、the National Block and Bridle Club的前任总裁,也曾担任the U.S. Beef Improvement Federation、National Cattlemen’s Beef Association、National Pork Board、Federated Animal Science Societies、the National Research Council的多种领导职务。他于2014年被任命为ASAS公司的会员。
Ronald D. Green is Associate Chief Accountant at the Institute of Agriculture and Natural Resources and Vice President of Agriculture and Natural Resources at the University of Nebraska System. He served as Senior Global Director for Technical Services for Pfizer Animal Health's Animal Genomics business (from 2008 to 2010). He also taught at Texas Tech University and Colorado State, and was a national program leader for animal production research for the USDA's Agricultural Research Service, As well as the White House's interagency Animal Genomics Working Group and the Executive Secretary of the National Science and Technology Council. He is the leader of the international cattle, pig and sheep genome sequencing project. He is the former president of the American Society of Animal Science (ASAS), the National Block and Bridle Club, Also served as the U.S. Beef Improvement Federation, National Cattlemen's Beef Association, National Pork Board, Federated Animal Science Societies Various leadership positions at the National Research Council. He was appointed a member of ASAS in 2014. - Ronald D. Green,他是农业和自然资源学院(the Institute of Agriculture and Natural Resources)的哈伦副总会计师,以及内布拉斯加州大学(University of Nebraska)系统的农业与天然资源的副总裁。他曾担任Pfizer Animal Health公司的动物基因组学企业的负责技术服务的高级全球董事(从2008年到2010年)。他也曾任教于德州理工大学(Texas Tech University)和科罗拉多州立大学(Colorado State),也曾担任美国农业部农业研究服务局(the USDA’s Agricultural Research Service)的动物生产研究的国家项目领导人,以及白宫跨部门的动物基因组学的工作集团和国家科学技术委员会(the National Science and Technology Council)的执行秘书。他是国际牛、猪和绵羊的基因组测序项目领导人。他是the American Society of Animal Science(ASAS)、the National Block and Bridle Club的前任总裁,也曾担任the U.S. Beef Improvement Federation、National Cattlemen’s Beef Association、National Pork Board、Federated Animal Science Societies、the National Research Council的多种领导职务。他于2014年被任命为ASAS公司的会员。
- Ronald D. Green is Associate Chief Accountant at the Institute of Agriculture and Natural Resources and Vice President of Agriculture and Natural Resources at the University of Nebraska System. He served as Senior Global Director for Technical Services for Pfizer Animal Health's Animal Genomics business (from 2008 to 2010). He also taught at Texas Tech University and Colorado State, and was a national program leader for animal production research for the USDA's Agricultural Research Service, As well as the White House's interagency Animal Genomics Working Group and the Executive Secretary of the National Science and Technology Council. He is the leader of the international cattle, pig and sheep genome sequencing project. He is the former president of the American Society of Animal Science (ASAS), the National Block and Bridle Club, Also served as the U.S. Beef Improvement Federation, National Cattlemen's Beef Association, National Pork Board, Federated Animal Science Societies Various leadership positions at the National Research Council. He was appointed a member of ASAS in 2014.
- Catherine E. Woteki
-
Catherine E.Woteki自2017年7月起担任爱荷华州立大学食品科学和人类营养教授,自2019年4月起担任弗吉尼亚大学生物复杂性研究所客座特聘研究所教授。从2010年到2016年,她担任USDA研究、教育和经济REE任务区的首席科学家和副秘书长。加入USDA之前,她曾担任Mars,Incorporated科学和监管事务全球总监,在那里她管理公司的健康、营养和食品安全监管政策。从2002年到2005年,她是爱荷华州州立大学农业实验站的负责人。1997年至2001年,Woteki博士担任美国农业部负责食品安全的第一副部长,负责监督肉类、禽类和蛋类产品的安全。Woteki博士是美国国家医学院的成员,也是美国科学促进会和美国营养学会的会员。
暂无英文简介 - Catherine E.Woteki自2017年7月起担任爱荷华州立大学食品科学和人类营养教授,自2019年4月起担任弗吉尼亚大学生物复杂性研究所客座特聘研究所教授。从2010年到2016年,她担任USDA研究、教育和经济REE任务区的首席科学家和副秘书长。加入USDA之前,她曾担任Mars,Incorporated科学和监管事务全球总监,在那里她管理公司的健康、营养和食品安全监管政策。从2002年到2005年,她是爱荷华州州立大学农业实验站的负责人。1997年至2001年,Woteki博士担任美国农业部负责食品安全的第一副部长,负责监督肉类、禽类和蛋类产品的安全。Woteki博士是美国国家医学院的成员,也是美国科学促进会和美国营养学会的会员。
- 暂无英文简介
- Aashima Gupta
-
Aashima Gupta是Google Cloud医疗服务提供商解决方案全球总监。她于2017年加入谷歌。Gupta女士是一位全球战略领导人,在卫生和技术交叉领域拥有超过25年的工作经验,在复杂的大型企业环境中拥有丰富的经验。在加入谷歌之前,古普塔曾在多家机构从事技术开发工作,包括NIIT、富达投资、摩根大通、Apigee和Kaiser Permanente。Gupta女士是Molnlycke的董事会成员,以及GRAIL和HIMSS NA的顾问委员会成员。2019年,古普塔女士被HIMSS评为医疗保健领域最具影响力的女性之一,并获得了FEMTech百强奖和健康冠军奖。古普塔女士被3M选为董事会成员,并根据FSD交易的条款,在年度会议上被提名为第三类董事。
暂无英文简介 - Aashima Gupta是Google Cloud医疗服务提供商解决方案全球总监。她于2017年加入谷歌。Gupta女士是一位全球战略领导人,在卫生和技术交叉领域拥有超过25年的工作经验,在复杂的大型企业环境中拥有丰富的经验。在加入谷歌之前,古普塔曾在多家机构从事技术开发工作,包括NIIT、富达投资、摩根大通、Apigee和Kaiser Permanente。Gupta女士是Molnlycke的董事会成员,以及GRAIL和HIMSS NA的顾问委员会成员。2019年,古普塔女士被HIMSS评为医疗保健领域最具影响力的女性之一,并获得了FEMTech百强奖和健康冠军奖。古普塔女士被3M选为董事会成员,并根据FSD交易的条款,在年度会议上被提名为第三类董事。
- 暂无英文简介
- Mikhael Nassif
-
Mikhael Nassif从Siemens Healthineers加入公司,自2022年9月起担任即时诊断全球总裁。在任职Siemens Healthineers之前,Nassif先生曾在百特国际有限公司(2017年3月至2022年9月)、百威英博(2015年4月至2017年3月)和强生(2009年5月至2015年4月)担任多个领导职务。
暂无英文简介 - Mikhael Nassif从Siemens Healthineers加入公司,自2022年9月起担任即时诊断全球总裁。在任职Siemens Healthineers之前,Nassif先生曾在百特国际有限公司(2017年3月至2022年9月)、百威英博(2015年4月至2017年3月)和强生(2009年5月至2015年4月)担任多个领导职务。
- 暂无英文简介
- Andrea F. Wainer
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Raphael A. Rodriguez
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Thierry L. Bernard
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Avi Pelossof
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- James C. Borel
-
James C. Borel,他于1978年加入DuPont公司,担任Agricultural Products公司的产品和销售管理职位。他于1993年搬到日本东京,任职Agricultural Products公司,担任北亚洲区域经理,并于1994年被任命为亚太地区区域主任。他于1997年被任命为北美区域董事,此后并被任命副总裁和总经理,负责杜邦农作物保护。他于2004年1月被任命为高级副总裁,负责杜邦公司全球人力资源。他于2008年成为集团副总裁,并于2009年10月被任命为执行副总裁,负责杜邦作物保护和先锋。他于2011年负责杜邦营养与健康,并于2014年负责公司的可持续发展。
James C. Borel joined DuPont in 1978 in product and sales management positions at Agricultural Products. He moved to Tokyo, Japan in 1993 as Regional Manager for North Asia at Agricultural Products, and was appointed Regional Director for Asia Pacific in 1994. He was appointed Regional Director for North America in 1997 and has since been appointed Vice President and General Manager, responsible for EIDP Crop Protection. He was appointed Senior Vice President in January 2004, responsible for EIDP's global human resources. He became Group Vice President in 2008 and was named Executive Vice President in October 2009, responsible for EIDP Crop Protection and Pioneer. He was in charge of EIDP Nutrition and Health in 2011 and the company's sustainability in 2014. - James C. Borel,他于1978年加入DuPont公司,担任Agricultural Products公司的产品和销售管理职位。他于1993年搬到日本东京,任职Agricultural Products公司,担任北亚洲区域经理,并于1994年被任命为亚太地区区域主任。他于1997年被任命为北美区域董事,此后并被任命副总裁和总经理,负责杜邦农作物保护。他于2004年1月被任命为高级副总裁,负责杜邦公司全球人力资源。他于2008年成为集团副总裁,并于2009年10月被任命为执行副总裁,负责杜邦作物保护和先锋。他于2011年负责杜邦营养与健康,并于2014年负责公司的可持续发展。
- James C. Borel joined DuPont in 1978 in product and sales management positions at Agricultural Products. He moved to Tokyo, Japan in 1993 as Regional Manager for North Asia at Agricultural Products, and was appointed Regional Director for Asia Pacific in 1994. He was appointed Regional Director for North America in 1997 and has since been appointed Vice President and General Manager, responsible for EIDP Crop Protection. He was appointed Senior Vice President in January 2004, responsible for EIDP's global human resources. He became Group Vice President in 2008 and was named Executive Vice President in October 2009, responsible for EIDP Crop Protection and Pioneer. He was in charge of EIDP Nutrition and Health in 2011 and the company's sustainability in 2014.
- Jeffrey D. Capello
-
Jeffrey D. Capello,2012年3月起担任Biogen Inc.董事。他现为医疗器械公司Boston Scientific Corporation的高级顾问。他于2008年6月加入Boston Scientific Corporation,担任高级副总裁、首席会计官,直到2010年3月;2010年3月至2013年12月,担任执行副总裁、首席财务官。之前,2006年至2008年6月,他担任科技公司PerkinElmer的高级副总裁、首席财务官,负责业务开发;此前,2002-2006,他担任其财务副总裁、企业财务总监、财务总管;2001-2005,担任财务副总裁、企业财务总监、首席会计官、财务总管。1991-2001,他在会计师事务所PricewaterhouseCoopers LLP担任过多个职务,其中包括1997-2001年间,担任合伙人。他从2008年1月起,担任Sirtris Pharmaceuticals的董事,直到2008年6月该公司被收购,也曾担任审核委员会的成员和主席。他获得了Vermont大学的工商管理学士学位、 Harvard Business School的工商管理硕士学位。他是注册会计师。
Jeffrey D. Capello has been a director of Biogen Inc. Since March 2012. He is currently a senior advisor to Boston Scientific Corporation, a medical device company. He joined Boston Scientific Corporation in June 2008 and served as Senior Vice President, Chief Accounting Officer until March 2010 and Executive Vice President and Chief Financial Officer from March 2010 to December 2013. Previously, from 2006 to June 2008, he was the Senior Vice President and Chief Financial Officer of PerkinElmer, a technology company, responsible for business development; previously, from 2002 to 2006, he served as its vice president of finance, corporate finance director and chief financial officer; from 2001 to 2005, he served as vice president of finance, corporate finance director, chief accounting officer and chief financial officer. From 1991 to 2001, he held various positions with the accounting firm PricewaterhouseCoopers LLP, including as a partner from 1997 to 2001. He was a director of Sirtris Pharmaceuticals from January 2008 until the company was acquired in June 2008 and also served as a member and chairman of the audit committee. He received a Bachelor of Business Administration from Vermont University and a Master of Business Administration from Harvard Business School. He is a certified public accountant. - Jeffrey D. Capello,2012年3月起担任Biogen Inc.董事。他现为医疗器械公司Boston Scientific Corporation的高级顾问。他于2008年6月加入Boston Scientific Corporation,担任高级副总裁、首席会计官,直到2010年3月;2010年3月至2013年12月,担任执行副总裁、首席财务官。之前,2006年至2008年6月,他担任科技公司PerkinElmer的高级副总裁、首席财务官,负责业务开发;此前,2002-2006,他担任其财务副总裁、企业财务总监、财务总管;2001-2005,担任财务副总裁、企业财务总监、首席会计官、财务总管。1991-2001,他在会计师事务所PricewaterhouseCoopers LLP担任过多个职务,其中包括1997-2001年间,担任合伙人。他从2008年1月起,担任Sirtris Pharmaceuticals的董事,直到2008年6月该公司被收购,也曾担任审核委员会的成员和主席。他获得了Vermont大学的工商管理学士学位、 Harvard Business School的工商管理硕士学位。他是注册会计师。
- Jeffrey D. Capello has been a director of Biogen Inc. Since March 2012. He is currently a senior advisor to Boston Scientific Corporation, a medical device company. He joined Boston Scientific Corporation in June 2008 and served as Senior Vice President, Chief Accounting Officer until March 2010 and Executive Vice President and Chief Financial Officer from March 2010 to December 2013. Previously, from 2006 to June 2008, he was the Senior Vice President and Chief Financial Officer of PerkinElmer, a technology company, responsible for business development; previously, from 2002 to 2006, he served as its vice president of finance, corporate finance director and chief financial officer; from 2001 to 2005, he served as vice president of finance, corporate finance director, chief accounting officer and chief financial officer. From 1991 to 2001, he held various positions with the accounting firm PricewaterhouseCoopers LLP, including as a partner from 1997 to 2001. He was a director of Sirtris Pharmaceuticals from January 2008 until the company was acquired in June 2008 and also served as a member and chairman of the audit committee. He received a Bachelor of Business Administration from Vermont University and a Master of Business Administration from Harvard Business School. He is a certified public accountant.
高管简历
中英对照 |  中文 |  英文- David H. Naemura
DavidH.Naemura自2015年3月起担任我们的首席财务官。作为首席财务官,Naemura先生管理盖茨的全球公司财务和会计职能,包括资本结构、资源分配、财务报告和全球内部控制系统的维护。Naemura先生还管理信息技术和Gates&8217;并购职能。此前,Naemura先生从2012年4月开始担任丹纳赫公司的集团首席财务官。在担任集团首席财务官期间,Naemura先生负责各种工业和电子终端市场的各种业务。在丹纳赫公司担任集团首席财务官之前,Naemura从2009年6月到2012年3月在Danaher担任平台首席财务官。Naemura先生之前也是Danaher的运营公司首席财务官。在加入Danaher之前,Naemura先生自2000年以来一直受雇于泰克公司(Tektronix Corporation),直到2007年被丹纳赫公司收购。Naemura先生也曾是一名审计师。
David H. Naemura,joined Neogen in November 2022 as Chief Financial Officer. Previously, Mr. Naemura served as the Senior Vice President and Chief Financial Officer of Vontier Corporation from February 2020 until November 2022. Mr. Naemura served as Chief Financial Officer of Gates Industrial Corporation from March 2015 to January 2020. Mr. Naemura led the financial reporting teams at each of Vontier Corporation and Gates Industrial Corporation. Prior to his time at Gates Industrial Corporation, Mr. Naemura served as Vice President of Finance and Group Chief Financial Officer at Danaher Corporation from April 2012 to March 2015, and previously served as Danaher Corporation's Test & Measurement Communications Platform Chief Financial Officer from January 2009 to April 2012. Prior to 2009, Mr. Naemura was employed by Tektronix Corporation from August 2000 to January 2009, including during its acquisition by Danaher Corporation in 2007.- DavidH.Naemura自2015年3月起担任我们的首席财务官。作为首席财务官,Naemura先生管理盖茨的全球公司财务和会计职能,包括资本结构、资源分配、财务报告和全球内部控制系统的维护。Naemura先生还管理信息技术和Gates&8217;并购职能。此前,Naemura先生从2012年4月开始担任丹纳赫公司的集团首席财务官。在担任集团首席财务官期间,Naemura先生负责各种工业和电子终端市场的各种业务。在丹纳赫公司担任集团首席财务官之前,Naemura从2009年6月到2012年3月在Danaher担任平台首席财务官。Naemura先生之前也是Danaher的运营公司首席财务官。在加入Danaher之前,Naemura先生自2000年以来一直受雇于泰克公司(Tektronix Corporation),直到2007年被丹纳赫公司收购。Naemura先生也曾是一名审计师。
- David H. Naemura,joined Neogen in November 2022 as Chief Financial Officer. Previously, Mr. Naemura served as the Senior Vice President and Chief Financial Officer of Vontier Corporation from February 2020 until November 2022. Mr. Naemura served as Chief Financial Officer of Gates Industrial Corporation from March 2015 to January 2020. Mr. Naemura led the financial reporting teams at each of Vontier Corporation and Gates Industrial Corporation. Prior to his time at Gates Industrial Corporation, Mr. Naemura served as Vice President of Finance and Group Chief Financial Officer at Danaher Corporation from April 2012 to March 2015, and previously served as Danaher Corporation's Test & Measurement Communications Platform Chief Financial Officer from January 2009 to April 2012. Prior to 2009, Mr. Naemura was employed by Tektronix Corporation from August 2000 to January 2009, including during its acquisition by Danaher Corporation in 2007.
- Amy M. Rocklin
Amy M.Rocklin于2021年3月加入Neogen,担任副总裁、总法律顾问和公司秘书。在这个职位上,她负责所有法律和合规事务,并担任公司秘书。在加入Neogen之前,Rocklin博士是康宁公司(全球领先的材料科学创新者之一)的部门副总裁,负责公司法律。在康宁工作的近十年中,她在康宁律师事务所(Corning’;S Law Department)担任多个领导职位,包括法律、并购和新兴创新总监。在康宁之前,Rocklin博士曾在Smiths Group plc任职,并在Foley&Lardner LLP律师事务所从事私人执业。
Amy M. Rocklin,joined Neogen in March 2021 as Vice President, General Counsel & Corporate Secretary. In 2022, Dr. Rocklin was named Chief Legal & Compliance Officer. In this role, she is responsible for all legal and compliance matters and also leads the regulatory, quality and ESG functions. Dr. Rocklin also serves as the Corporate Secretary. Prior to joining Neogen, Dr. Rocklin was Division Vice President, Corporate Law at Corning Incorporated. In her nearly ten years at Corning, she held multiple leadership positions within Corning's Law Department. Before Corning, Dr. Rocklin held leadership positions at Smiths Group plc and was in private practice at the law firm of Foley & Lardner LLP.- Amy M.Rocklin于2021年3月加入Neogen,担任副总裁、总法律顾问和公司秘书。在这个职位上,她负责所有法律和合规事务,并担任公司秘书。在加入Neogen之前,Rocklin博士是康宁公司(全球领先的材料科学创新者之一)的部门副总裁,负责公司法律。在康宁工作的近十年中,她在康宁律师事务所(Corning’;S Law Department)担任多个领导职位,包括法律、并购和新兴创新总监。在康宁之前,Rocklin博士曾在Smiths Group plc任职,并在Foley&Lardner LLP律师事务所从事私人执业。
- Amy M. Rocklin,joined Neogen in March 2021 as Vice President, General Counsel & Corporate Secretary. In 2022, Dr. Rocklin was named Chief Legal & Compliance Officer. In this role, she is responsible for all legal and compliance matters and also leads the regulatory, quality and ESG functions. Dr. Rocklin also serves as the Corporate Secretary. Prior to joining Neogen, Dr. Rocklin was Division Vice President, Corporate Law at Corning Incorporated. In her nearly ten years at Corning, she held multiple leadership positions within Corning's Law Department. Before Corning, Dr. Rocklin held leadership positions at Smiths Group plc and was in private practice at the law firm of Foley & Lardner LLP.
- Mikhael Nassif
Mikhael Nassif从Siemens Healthineers加入公司,自2022年9月起担任即时诊断全球总裁。在任职Siemens Healthineers之前,Nassif先生曾在百特国际有限公司(2017年3月至2022年9月)、百威英博(2015年4月至2017年3月)和强生(2009年5月至2015年4月)担任多个领导职务。
暂无英文简介- Mikhael Nassif从Siemens Healthineers加入公司,自2022年9月起担任即时诊断全球总裁。在任职Siemens Healthineers之前,Nassif先生曾在百特国际有限公司(2017年3月至2022年9月)、百威英博(2015年4月至2017年3月)和强生(2009年5月至2015年4月)担任多个领导职务。
- 暂无英文简介
- John Patrick Moylan
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Bryan Riggsbee
布赖恩·里格斯比(Bryan Riggsbee)加盟Neogen公司之前任职于生物梅里埃,最近担任该公司北美地区首席财务官,负责监管该地区价值20亿美元的业务和多个制造基地。在此之前,Riggsbee先生在万基遗传担任了近十年的首席财务官,在那里他领导公司的财务、会计和投资者关系职能,并在扩大公司的投资组合和合作伙伴关系以及支持进入新的国际市场的增长方面发挥了关键作用。在其职业生涯的早期,他曾在美国实验室公司(LabCorp)、GE和毕马威会计师事务所担任高级财务职务。Riggsbee目前在CareDx公司董事会任职,该公司于2024年3月获得任命。他拥有北卡罗来纳大学教堂山分校政治学学士学位和北卡罗来纳州立大学会计学学士学位,以及西北大学家乐氏管理学院MBA学位。兼任注册会计师(CPA)。
Bryan Riggsbee,joins Neogen from bioMérieux, where he most recently served as Chief Financial Officer, North America, overseeing a $2 billion business and multiple manufacturing sites across the region. Prior to that, Mr. Riggsbee spent nearly a decade as Chief Financial Officer at Myriad Genetics, where he led the company's finance, accounting, and investor relations functions and played a key role in expanding the company's portfolio and partnerships, as well as supporting growth into new international markets. Earlier in his career, he held senior finance roles at Laboratory Corporation of America (LabCorp), GE, and KPMG.Mr. Riggsbee currently serves on the Board of Directors of CareDx, Inc., having been appointed in March 2024. He holds bachelor's degrees in Political Science from the University of North Carolina at Chapel Hill and in Accounting from North Carolina State University, as well as an MBA from Northwestern University's Kellogg School of Management. He is also a Certified Public Accountant (CPA).- 布赖恩·里格斯比(Bryan Riggsbee)加盟Neogen公司之前任职于生物梅里埃,最近担任该公司北美地区首席财务官,负责监管该地区价值20亿美元的业务和多个制造基地。在此之前,Riggsbee先生在万基遗传担任了近十年的首席财务官,在那里他领导公司的财务、会计和投资者关系职能,并在扩大公司的投资组合和合作伙伴关系以及支持进入新的国际市场的增长方面发挥了关键作用。在其职业生涯的早期,他曾在美国实验室公司(LabCorp)、GE和毕马威会计师事务所担任高级财务职务。Riggsbee目前在CareDx公司董事会任职,该公司于2024年3月获得任命。他拥有北卡罗来纳大学教堂山分校政治学学士学位和北卡罗来纳州立大学会计学学士学位,以及西北大学家乐氏管理学院MBA学位。兼任注册会计师(CPA)。
- Bryan Riggsbee,joins Neogen from bioMérieux, where he most recently served as Chief Financial Officer, North America, overseeing a $2 billion business and multiple manufacturing sites across the region. Prior to that, Mr. Riggsbee spent nearly a decade as Chief Financial Officer at Myriad Genetics, where he led the company's finance, accounting, and investor relations functions and played a key role in expanding the company's portfolio and partnerships, as well as supporting growth into new international markets. Earlier in his career, he held senior finance roles at Laboratory Corporation of America (LabCorp), GE, and KPMG.Mr. Riggsbee currently serves on the Board of Directors of CareDx, Inc., having been appointed in March 2024. He holds bachelor's degrees in Political Science from the University of North Carolina at Chapel Hill and in Accounting from North Carolina State University, as well as an MBA from Northwestern University's Kellogg School of Management. He is also a Certified Public Accountant (CPA).